![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 17, 17443-17448, April 23, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



From the
Departments of
Pathology and Laboratory Medicine, ¶Cell & Developmental Biology, and ||Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennyslvania 19104
Received for publication, October 29, 2003 , and in revised form, January 30, 2004.
| ABSTRACT |
|---|
|
|
|---|
mep2
mep3
) and a wild-type strain. RhAG was able to complement the transport mutant, with complementation strictly pH-dependent, requiring pH 6.26.5. RhAG also conferred resistance to methylamine (MA), a toxic analog of ammonium, and expression in wild-type cells revealed that resistance was correlated with efflux of MA. RhAG-mediated resistance was pH-dependent, being optimal at acid pH. The opposite pH dependence of ammonium complementation (uptake) and MA resistance (efflux) is consistent with bidirectional movement of substrate counter to the direction of the proton gradient. This report clarifies and expands previous observations of RhAG-mediated transport in yeast and supports the hypothesis that ammonium transport is coupled to the H+ gradient and that RhAG functions as a NH4+/H+ exchanger. | INTRODUCTION |
|---|
|
|
|---|
In addition to the erythrocyte proteins (RhAG, RhCE, and RhD), nonerythroid homologs, designated RhCG and RhBG, are present in the kidney, liver, brain, skin, and testis (37). All have a predicted 12-transmembrane structure with intracellular N and C termini, and they lack consensus ATP binding sites. Rh homologs are also present in invertebrates from the sponge to the fly and in vertebrates from frogs to primates, suggesting that Rh blood group proteins are members of an ancient family of proteins with an important conserved function.
Protein sequences with similarities to Rh and RhAG were first found in Caenorhabditis elegans; these homologs, in turn, showed a distant similarity with ammonium transporters from bacteria (SNYN, AMT), yeast (MEP), and plants (AMT). In these organisms, transport of ammonia (NH3)/ammonium (NH4+) is critical for acquisition of nitrogen. Whereas uptake in these organisms is thought to occur primarily by diffusion of NH3 into the cells when the concentration of NH4+ in the medium is optimal, expression of the specific transporter proteins is induced when NH4+ is limiting. Neither the mechanism(s) of transport nor the substrate(s) transported (protonated NH4+ or unprotonated NH3) by these ammonium transport proteins have been definitively determined, although it is an active area of investigation and debate (8, 9).
We reported recently that erythroid RhAG expressed in Xenopus laevis oocytes mediates uptake of ammonium, providing direct evidence for a transport function (10). Characterization in oocytes revealed that uptake was independent of the membrane potential and the Na+ gradient but that raising extracellular pH or lowering intracellular pH dramatically stimulated uptake. These results suggested that uptake was coupled to an outwardly directed H+ gradient and led us to hypothesize that RhAG might function by an H+-coupled, counter-transport mechanism.
Here we have attempted to gain further insights into the function of RhAG by heterologous expression in either mutant yeast that were deficient in ammonium uptake from the medium or in wild-type (WT) yeast. Expression of RhAG complemented the ammonium transport mutant in a strictly pH-dependent manner (pH 6.26.5). Furthermore, RhAG expression also conferred resistance to methylamine (MA), an ammonium analog that is toxic when present at high concentrations in yeast medium, with RhAG-mediated efflux of MA correlating with resistance. RhAG conferred both uptake and efflux of ammonium in yeast, depending on the pH of the medium. Complementation (uptake) occurred at pH
6.1, whereas resistance (efflux) was favored at the acid pH values common in yeast cultures. The opposing pH dependences of uptake and efflux suggest that transport is coupled to the H+ gradient and is consistent with the hypothesis that RhAG functions by NH+/H4+ exchange. This report clarifies and expands previous observations and provides a hypothesis for the mechanism of RhAG-mediated transport.
| EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
mep2
mep3
or mep 13
), and the MLY61 wild-type (WT) parental strain, were a kind gift from Joseph Heitman (Duke University, Durham, NC) (11). Standard yeast media without amino acids and ammonium sulfate (Difco Laboratories, Detroit, MI) with limiting nitrogen at concentrations of 110 mM (NH4)2SO4 and alternative nitrogen media (0.1% proline) were prepared with 2% glucose or 2% galactose as carbon sources and 2% Noble agar. Where indicated, media were buffered with 20 mM Tris-HCl or MES, and pH was adjusted with NaOH or acetic acid. The MEP genes are repressed when cultured with a good nitrogen source (glutamine or ammonium) and induced on a poor nitrogen source such as proline. Induction medium consisted of 0.17% yeast nitrogen base without ammonium sulfate or amino acids supplemented with 0.1% proline and 2% galactose. Galactose was required for induction of RhAG expression.
PlasmidsControl plasmids containing MEP1 (pML100), MEP2 (pML151), and MEP3 (pML113) were also from J. Heitman (11). These plasmids contain
500 bp of 5'-endogenous promoter DNA and carry the URA3 selectable marker. Full-length RhAG cDNA was cloned downstream of the galactose-inducible GAL1 promoter in pYES2-URA3 and was verified by sequencing. A MEP1/RHAG co-expression vector was created by insertion of MEP1 as a ClaI/SpeI fragment into the vector pYES2-RhAG at the ClaI/NheI site located outside the polylinker. Cloning and propagation of plasmids followed standard procedures in Escherichia coli XL-Blue. Yeast strains were transformed with the pYES2-RhAG construct, the individual MEP control plasmids, or the empty vector using lithium acetate, and transformants were plated on minimal medium lacking uracil.
[14C]MA Uptake and EffluxRadiolabeled [14C]MA (CH3NH3+) (ICN Biomedicals, Irvine, CA) uptake was performed with RhAG-expressing cells and control cells transformed with the empty pYES2 vector or MEP1-, MEP2-, or MEP3-encoding vectors. Cells were grown overnight in ura-DO/0.67% yeast nitrogen base/2% glucose. Mid-log phase cells were washed with ice-cold water, diluted to A600 0.81.0, and induced for either 5 h or overnight at 30 °C in minimal medium, pH 6.16.5, containing proline as the sole nitrogen source and 2% galactose. The time course of [14C]MA (specific activity, 5 x 105 cpm/µmol) uptake was determined with a final concentration of 0.5 mM MA, as described previously (12). Briefly, 500 µl of 5 mM methylammonium containing 0.5 µCi of [14C]MA was added to 4.5 ml of the culture. Uptake was determined by removing samples (500 µl) at timed intervals to 25-mm diameter membrane filters (0.45 µm; Millipore) on a suction apparatus. Cells on the filter were washed by suction with 10 ml of cold water, and the filters were then placed in vials containing 5 ml of scintillation counting fluid, and counted. The time course of [14C]MA efflux was determined by addition of 10 mM cold MA to cells loaded 45 h or overnight with [14C]MA, followed by removal of cell aliquots to filters, washing, and counting of residual cellular [14C]MA, as above. All uptake and efflux measurements were standardized to a concentration of 1 OD (
5 x 107 cells/ml) and were expressed as nanomoles per optical density of cells.
Western AnalysisYeast cultures were induced overnight and harvested in 5 OD aliquots. Membrane extracts were prepared by glass bead agitation in 200 µl of lysis buffer containing 0.1 M Tris-Cl, pH 7.5, 0.15 M NaCl, 5 mM EDTA, and protease inhibitors phenylmethylsulfonyl fluoride (0.2 mM), pepstatin, leupeptin, aprotinin, and chymostatin (2 µg/ml each) at 4 °C. The cells were lysed by vortex mixing for 3 min, diluted 23-fold with lysis buffer, and centrifuged at 3,000 rpm for 3 min. The supernatant was removed and centrifuged for 45 min at 13,000 rpm to obtain a pellet. The pellet was resuspended in sample loading buffer containing 8 M urea, heated at 37 °C for 15 min, and analyzed by SDS-PAGE followed by immunoblotting. RhAG protein expression was detected with monoclonal antibody 2D10 (13), or with anti-HA when expressing a RhAG-HA tagged construct, and visualized with secondary horseradish peroxidase-conjugated anti-mouse IgG followed by ECL chemiluminescence (Amersham Biosciences).
Data AnalysisExperimental data were analyzed with IGOR software (Wavemetrics, Lake Oswego, OR). Uptake rates were determined from slopes of linear fits measured over 30 min. Efflux rates were determined by calculation of Aexp (-t/c). Statistical significance was evaluated by two-tailed paired t test. A p value < 0.05 was considered significant. Arithmetic means are given as mean ± S.E.
| RESULTS |
|---|
|
|
|---|
(mep1
mep2
mep3), renders cells non-viable on medium containing 15 mM ammonium sulfate as the sole nitrogen source (14). We reasoned that if RhAG were to function as an ammonium transporter, its expression in yeast might complement the transport defect in the mep13
cells. To determine whether RhAG can functionally substitute for the Mep proteins, we expressed RhAG in the mep13
ammonium transport mutant. Furthermore, we expressed RhAG in WT yeast to evaluate its effects on endogenous ammonium transport and accumulation.
Western Blot Analysis of RhAG Expression in S. cerevisiae Membrane-enriched fractions of cell extracts from WT and the mep13
transport mutant transformed with the pYES-RHAG construct were separated on SDS-PAGE gels and probed with a RhAG antibody to confirm that erythroid RhAG protein could be expressed in yeast (Fig 1A). Expression was confirmed in the WT cells, but RhAG expression in the mep13
mutant was not observed when probed with this 2D10 antibody. Because this antibody probably recognizes a carbohydrate epitope on the extracellular side of RhAG (13), we suspected that processing was different in the mep13
cells. When we expressed an HA-epitope-tagged RhAG construct in the mutant mep13
cells, RhAG-HA expression could be detected with a HA antibody and migrated at a lower molecular weight (
40 kDa; data not shown) than RhAG expressed in the WT strain. This result is consistent with the observed size of RhAG expressed in a yeast ammonium transport mutant by Marini et al. (18), and it suggests that RhAG transits through the ER differently when expressed in the mep13
mutant compare with WT.
|
Ammonium Transport Mutant at pH 6.16.5To determine whether RhAG expression can complement the transport defect in the mep13
cells, the mutant cells were transformed with RhAG and plated on nitrogen-free medium supplemented with 15 mM ammonium sulfate. In addition, either 2% galactose was added to induce RhAG expression or 2% glucose was added as the uninduced control. Additional controls included the mutant cells transformed with either the empty vector or with the endogenous ammonium transport genes MEP1, MEP2, or MEP3. The plates were then incubated at 30 °C and observed for 2 weeks. Expression of RhAG failed to restore growth of the mutant cells under these conditions. These initial experiments were performed using yeast medium that is acidic with approximate pH 4.9. Yeast can grow well at this pH because they are capable of extruding acid even in medium with pH 3.0 (16). Because the optimal pH in some transport studies in yeast was reported to be
5.5 (16), we repeated the complementation experiments using buffered media with pH ranging from 4.2 to 7.2 (Fig 1B). At pH 7.2, the growth disadvantage of the mep13
mutant on low ammonium disappears, as observed previously (9), and growth of all cells was equivalent. After extended incubation (
5 days at 30 °C), growth of the RhAG-transformed mutant cells plated on galactose at pH 6.2 was enhanced compared with uninduced cells plated on glucose. Although the complementation was relatively weak compared with that seen with the native yeast MEP genes, the enhanced growth was consistently observed in repeated experiments using media adjusted from pH 6.2 to 6.5. In contrast, no complementation was observed at more acidic pH values.
Methylamine (MA+,CH3NH3+), the methyl analog of ammonium, has been used previously in studies of ammonium transport in S. cerevisiae (17). We demonstrated previously that MA+ and NH4+ have similar affinities for the RhAG transport pathway when expressed in oocytes (10); therefore, we measured the time course of radiolabeled [14C]MA uptake in RhAG-transfected and control mutant yeast cells (Fig 2A). The control mutant mep13
cells transformed with either MEP1 or MEP2 demonstrated significantly enhanced [14C]MA uptake, with MEP3 accumulating less, consistent with previous reported affinities (14). However, there was no measurable enhancement of accumulation of the radioactive substrate in RhAG-transformed cells relative to those with empty vector (Fig. 2A), consistent with results from a previous report (18). The inability to observe enhanced initial uptake rates or accumulation of tracer MA in the mep13
/RhAG cells measured over minutes to an hour was not inconsistent with the observation that an extend incubation time (
5 days) on solid medium was required to observe the weak growth complementation. These results suggested that RhAG does transport MA as efficiently as native Mep proteins. It is noteworthy that the yeast Mep proteins function not only in ammonium uptake but also are important for substrate retention (11, 14). We therefore considered an alternative approach to investigate the mechanism of RhAG-mediated transport in yeast by expressing RhAG in WT cells to evaluate its effects on endogenous ammonium transport and accumulation.
|
cells are resistant to these concentrations (9, 14). To determine whether RhAG expression could influence either of these phenotypes, WT and mep13
cells expressing RhAG were plated on media supplemented with 50 mM MA. Expression of RhAG had no effect on mep13
cell resistance to 50 mM MA, whereas it conferred a dramatic resistance to MA in the WT cells (Fig. 3A).
|
null background. Expression of Mep1 results in significant [14C]MA uptake; importantly, however, co-expression of RhAG (MEP1/RHAG) significantly decreased accumulation of [14C]MA compared with expression of Mep 1 alone (Fig. 2B). Similarly, co-expression of RhAG with either Mep 2 or Mep 3 in the mep13
null background dramatically decreased mep-mediated MA accumulation (not shown). These data suggest that RhAG was specifically antagonizing the Mep-mediated transport process by inhibiting MA uptake or by stimulating MA efflux.
To determine the mechanism by which expression of RhAG confers resistance to toxic concentrations of MA in WT cells, we measured and compared [14C]MA uptake and accumulation in WT/empty vector and WT/RhAG cells (Fig. 3B). The rate of accumulation, as well as the total MA accumulated, was significantly less in the WT/RhAG-expressing cells. Resistance to toxic compounds can result from sequestration of the compound into the vacuole (16). If expression of RhAG conferred resistance to MA toxicity by stimulating MA accumulation into the vacuole, the total accumulation of [14C]MA in the RhAG-expressing cells would be expected to be either similar to or greater than that observed in WT cells, but this was not observed. RhAG expression in WT cells resulted in more than a 50% reduction (
64% at 1 h) in MA accumulation. To clarify that RhAG expression was not inhibiting MA uptake, we measured initial uptake in WT and WT/RhAG cells (Fig. 3B, inset). Measurable accumulation in the first 60 s was equivalent, suggesting that inhibition of the endogenous Mep proteins was not the mechanism of rescue.
To test the hypothesis that RhAG-mediated resistance involved efflux of MA, WT/empty vector and WT/RhAG cells were loaded with [14C]MA, and the efflux rate was determined by measuring the amount of [14C]MA in the cells after the addition of 10 mM unlabeled MA. Cell aliquots were removed to filters at timed intervals, washed, and the remaining cellular radioactivity was counted. The rate of MA efflux from WT/RhAG cells was
60% greater (p < 0.001) than that measured for WT/empty vector cells (Fig. 4A). This result suggests that RhAG confers resistance to MA toxicity in WT cells by stimulating MA efflux.
|
RhAG-mediated MA Resistance Is pH-dependentTo determine whether the pH of the medium was important for RhAG-mediated resistance of WT cells to MA toxicity, as established for complementation of ammonium uptake in mep13
mutant cells (above), as well as to determine the maximum MA concentration above which RhAG could no longer mediate resistance, cells were plated on media buffered from pH 4.5 to 7.5 and supplemented with 50 mM1 M MA. WT cells did not grow when the medium contained 50 mM MA, consistent with previous results (9). RhAG expression conferred resistance to varying concentrations of MA, depending on the pH of the medium (Fig. 5A). At pH 4.5, RhAG conferred resistance to 1 M MA, but RhAG-mediated resistance declined as pH increased, until no resistance was observed at pH 7.5.
|
mutant is resistant to MA but is nevertheless sensitive to very high MA concentrations (Fig. 5B). Sensitivity of the mep13
mutant probably results from passive membrane permeation of unprotonated MA, which probably diminishes the membrane proton gradient and neutralizes acidic compartments (9). To determine whether expression of RhAG could confer resistance to these high MA concentrations in the mep13
mutant cells, we plated mep13
/empty vector- and mep13
/RhAG-transformed cells on medium with various concentrations of MA with pH buffered from 4.5 to 7.5, as was done for WT cells. RhAG expression conferred resistance to the mep13
mutant in a pH-dependent manner (Fig. 5B). Resistance extended to equivalent MA concentration levels in both WT and mep13
mutant cells expressing RhAG.
In summary, expression of RhAG conferred resistance in both WT and mep13
mutant yeast strains to approximately equivalent concentrations of MA. These results suggest that the mechanism of RhAG-mediated resistance was the same in both WT cells and in the ammonium transport mutant cells. Thus, RhAG function in yeast is independent of the presence or absence of the endogenous transporters and does not involve inhibition of endogenous ammonium uptake mechanisms. In contrast, RhAG expression stimulated MA efflux rates, which suggests that enhanced MA extrusion is responsible for resistance conferred by its expression. In addition, RhAG-mediated resistance to MA toxicity was influenced by medium pH, being greatest at pH 4.5, with no resistance conferred at pH 7.5. This suggests that RhAG-mediated MA efflux is pH-dependent, promoted by the H+ gradient.
| DISCUSSION |
|---|
|
|
|---|
) and the parental wild-type (WT) strain.
When expressed in the mep13
transport mutant, RhAG complemented the growth defect observed in media with low ammonium concentrations. Whereas this result is consistent with a previous report (18), we found that complementation was highly pH-dependent. The growth enhancement conferred by RhAG expression was only observed after extended incubation in medium buffered above pH 6.1, whereas it did not occur at the acid pH values common in yeast culture media. This pH requirement for RhAG-mediated complementation correlates with the predicted plasma membrane proton gradient (Table I). The intracellular pH (pHi) in yeast is correlated with the pH of the medium (pHo) (19). At acidic pHo 4.35.3, the pHi is relatively alkaline, so the direction of the proton gradient is inward. However, at pHo 6.26.9, pHi is lower, so the proton gradient is directed outward. This reversal in the proton gradient at pH 6.2 correlates with the pH requirement (>6.1) we observed for RhAG-mediated complementation of ammonium uptake in the mep13
mutant yeast. These results therefore suggest that RhAG-mediated ammonium uptake requires an outwardly directed proton gradient (Fig 6A).
|
|
cells that expressed RhAG could not be measured, which is consistent with results from another group (18), but differs from our observations in X. laevis oocytes in which enhanced uptake was observed with RhAG expression (10). The inability to detect [14C]MA accumulation in RhAG-expressing mep13
mutant yeast cells over a 12-h time period is perhaps not inconsistent with the extended incubation (
5 days) required to observe complementation. The different observation in yeast and oocytes probably reflects their distinct physiology. Indeed, in yeast, the membrane potential is maintained via the H+-ATPase, and metabolic extrusion of protons causes acidification of the medium (16). Consequently, an inwardly directed proton gradient develops in yeast culture, which would diminish the proton gradient required for ammonium uptake. The small magnitude of the outward proton gradient at pHo 6.2 (
0.2 pH units) in yeast cells probably accounts for the weak complementation and the failure to measure flux uptake.
When expressed in either WT cells or in the mep13
mutant cells, RhAG expression conferred resistance to toxic concentrations of MA. The mechanism of resistance was investigated in detail in the WT cells, because they accumulated measurable amounts of [14C]MA that enabled measurements of RhAG-mediated fluxes of MA. We found that resistance was associated with MA efflux. The rate of efflux from WT/RhAG cells was
60% greater than that measured from WT cells. This was consistent with the 5064% reduction in accumulation of MA in WT/RhAG-expressing cells compared with WT cells. In contrast to ammonium uptake complementation, the enhanced MA efflux conferred by RhAG expression was potentiated at acid pHo, where the direction of the proton gradient is inward.
These results taken together suggest that RhAG can function bi-directionally in yeast, mediating either uptake or efflux of substrate (Fig. 6A). The opposing pH dependences of complementation and resistance suggests that MA/ammonium movement is influenced by the pH gradient across the plasma membrane, supporting the hypothesis that RhAG-mediated transport is driven by the proton gradient. The observation that RhAG was more effective at mediating efflux of MA/ammonium (resistance to MA toxicity) than at mediating influx of MA/ammonium (complementation of mep deficiency) when expressed in yeast is consistent with the magnitude of the pH gradient across the yeast plasma membrane under the two assay conditions. Taken together, the results we have obtained in yeast are in good agreement with those obtained in frog oocytes (10), and they support a model in which RhAG-mediated ammonium transport is coupled to H+ transport in the opposite direction.
The actual substrate transported by RhAG, unprotonated NH3, and/or protonated NH4+, or both, has not been unequivocally determined. Investigation of ammonium/MA transport is complicated because unprotonated forms can diffuse across biological membranes. MA is a weak base, and because the uncharged species is lipid-soluble, it has been used to estimate the pH gradient across membranes. At a given concentration of MA (pKa 10.6), the unprotonated species increases
10-fold with each pH unit (Fig. 5B). At high concentrations of MA, membrane permeation of the unprotonated species will diminish the proton gradients across the yeast plasma and vacuolar membranes. The resulting loss of driving force for nutrient uptake and the neutralization of acidic compartments are detrimental to growth (9). The ability of unprotonated-MA permeation to disrupt intracellular pH gradients will depend on the activities of other mechanisms to defend them, particularly the H+-ATPase. The MA sensitivity of the untransformed mep13
mutant cells that lack the Mep transporters reflects these effects of membrane permeation of unprotonated MA. As shown in Fig. 5B, the untransformed mep13
mutant cells are sensitive to MA at pH 4.5 at unprotonated MA concentrations between approximately 0.50.6 µM, but the cells are much less sensitive at pH 6.5, requiring MA concentrations nearly 20 times greater to induce toxicity. The activity of the yeast H+-ATPase is optimum at pH 6.06.5 (16) with markedly less activity (6230% of the maximum level) at pH 4.02.4 (20). Thus, the proton pump is able to defend cellular proton gradients against MA-induced disruption well at pH 6.5 but weakly at pH 4.5. As further evidence that yeast sensitivity to high concentrations of MA is related to diminishing the proton gradient, we observed that untransformed control WT and mep13
cells were more resistant to MA at pH 4.55.5 when glucose, rather than galactose, was provided as the carbon source (data not shown). Glucose metabolism causes intracellular acidification, and both the yeast plasma membrane H+-ATPase and the vacuolar V-ATPase, which is responsible for organelle acidification, are activated by glucose (21).
Taken together, these observations are consistent with diminished proton gradients as the mechanism for MA toxicity, and they raise the interesting possibility that the RhAG-mediated resistance to high concentrations of MA (>1 M at pH 4.5) not only reduces the MA load but also provides protons (illustrated in Fig. 6B). A model that can account for the marked resistance to MA conferred in yeast by the expression of RhAG is one in which RhAG mediates exchange of cationic MA+ with H+. Thus, we suggest that the influx of protons may be critical to the mechanism of RhAG-mediated resistance to MA toxicity in yeast and is consistent with our hypothesis that RhAG functions by H+/NH4+ exchange.
| FOOTNOTES |
|---|
To whom reprint requests should be addressed: 510 Stellar Chance, Philadelphia, PA 19104; Tel.: 215-898-1372; Fax: 215-573-8944; E-mail: westhoff{at}mail.med.upenn.edu.
1 The abbreviations used are: RhAG, Rh-associated glycoprotein; MA, methylamine; WT, wild type; MES, 2-(N-morpholino)ethanesulfonic acid. ![]()
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. Cherif-Zahar, A. Durand, I. Schmidt, N. Hamdaoui, I. Matic, M. Merrick, and G. Matassi Evolution and Functional Characterization of the RH50 Gene from the Ammonia-Oxidizing Bacterium Nitrosomonas europaea J. Bacteriol., December 15, 2007; 189(24): 9090 - 9100. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, S. Jayachandran, H.-H. T. Nguyen, and M. K. Chan Structure of the Nitrosomonas europaea Rh protein PNAS, December 4, 2007; 104(49): 19279 - 19284. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakada, K. Hoshijima, M. Esaki, S. Nagayoshi, K. Kawakami, and S. Hirose Localization of ammonia transporter Rhcg1 in mitochondrion-rich cells of yolk sac, gill, and kidney of zebrafish and its ionic strength-dependent expression Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1743 - R1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakada, C. M. Westhoff, A. Kato, and S. Hirose Ammonia secretion from fish gill depends on a set of Rh glycoproteins FASEB J, April 1, 2007; 21(4): 1067 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Klumpp and D. L. Siegel Transfusion medicine ASH Self-Assessment Program, January 1, 2007; 2007(1): 408 - 443. [Full Text] [PDF] |
||||
![]() |
K.-H. Han, B. P. Croker, W. L. Clapp, D. Werner, M. Sahni, J. Kim, H.-Y. Kim, M. E. Handlogten, and I. D. Weiner Expression of the Ammonia Transporter, Rh C Glycoprotein, in Normal and Neoplastic Human Kidney J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2670 - 2679. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Seshadri, J. D. Klein, T. Smith, J. M. Sands, M. E. Handlogten, J. W. Verlander, and I. D. Weiner Changes in subcellular distribution of the ammonia transporter, Rhcg, in response to chronic metabolic acidosis Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1443 - F1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ji, S. Hashmi, Z. Liu, J. Zhang, Y. Chen, and C.-H. Huang CeRh1 (rhr-1) is a dominant Rhesus gene essential for embryonic development and hypodermal function in Caenorhabditis elegans PNAS, April 11, 2006; 103(15): 5881 - 5886. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Monahan, M. C. Askin, M. J. Hynes, and M. A. Davis Differential Expression of Aspergillus nidulans Ammonium Permease Genes Is Regulated by GATA Transcription Factor AreA Eukaryot. Cell, February 1, 2006; 5(2): 226 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-O. D. Mak, B. Dang, I. D. Weiner, J. K. Foskett, and C. M. Westhoff Characterization of ammonia transport by the kidney Rh glycoproteins RhBG and RhCG Am J Physiol Renal Physiol, February 1, 2006; 290(2): F297 - F305. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Seshadri, J. D. Klein, S. Kozlowski, J. M. Sands, Y.-H. Kim, K.-H. Han, M. E. Handlogten, J. W. Verlander, and I. D. Weiner Renal expression of the ammonia transporters, Rhbg and Rhcg, in response to chronic metabolic acidosis Am J Physiol Renal Physiol, February 1, 2006; 290(2): F397 - F408. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mayer, G. Schaaf, I. Mouro, C. Lopez, Y. Colin, P. Neumann, J.-P. Cartron, and U. Ludewig Different Transport Mechanisms in Plant and Human AMT/Rh-type Ammonium Transporters J. Gen. Physiol., January 30, 2006; 127(2): 133 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Handlogten, S.-P. Hong, C. M. Westhoff, and I. D. Weiner Apical ammonia transport by the mouse inner medullary collecting duct cell (mIMCD-3) Am J Physiol Renal Physiol, August 1, 2005; 289(2): F347 - F358. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khademi, J. O'Connell III, J. Remis, Y. Robles-Colmenares, L. J. W. Miercke, and R. M. Stroud Mechanism of Ammonia Transport by Amt/MEP/Rh: Structure of AmtB at 1.35 A Science, September 10, 2004; 305(5690): 1587 - 1594. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||